Echo Drugs INC

Echo Drugs INC was paid $25K by Medicaid between May 2018 and Nov 2024, across 7 billing codes. Its largest line is A4239, Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service — 84% of everything it billed.

33Billing provider infoECHO DRUGS INC
BROOKLYN, NY 11211

33aNPI1275618563assigned 10/26/2006

33bProvider typeSpecialty Pharmacy

28Total paid$25K

24GClaims4,401

24DCodes billed7

24AFirst – last monthMay 2018 – Nov 2024

Compared with peers

Next to other Specialty Pharmacy providers in New York

Rank by total paid#7 of 11

Median peer was paid$27K

This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	90	$0.00
2019	422	$0.00
2020	1,042	$768.35
2021	959	$572.86
2022	449	$3K
2023	582	$5K
2024incomplete	857	$16K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	84%	564	561	$21K
J7507	Tacrolimus, immediate release, oral, 1 mg	8.1%	683	464	$2K
K0553	Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	7.5%	43	43	$2K
J7517	Mycophenolate mofetil, oral, 250 mg	<1%	27	24	$101.52
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	761	710	$66.28
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	<1%	1,478	811	$3.55
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	0%	845	797	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRIVKIN, RONEL (PRESIDENT)